MyChart is not for medical emergencies. If you have a medical emergency, call 911.
If you need help with MyChart, call us at 1-844-442-4278
University of Chicago Medicine medical oncologists are skilled at managing all types of breast cancers, with special expertise in aggressive forms of the disease, such as triple-negative breast cancer. We offer the latest systemic therapies — drugs that fight cancer cells almost anywhere in the body — for breast cancer, including:
Neoadjuvant therapies are additional treatments (typically chemotherapy or hormone therapy) to shrink the tumor(s), given before surgical removal of the cancer. Neoadjuvant therapy allows physicians to better understand how an individual's cancer responds to therapy, so the treatment plan can be adjusted accordingly. It also opens the gateway for patients to access newer chemotherapies.
Adjuvant therapies are treatments given after surgical removal of the cancer. Types of adjuvant therapies include:
Through our breast cancer clinical trials program, we offer many promising emerging systemic therapies not widely available at other institutions.
Like many women after learning of a breast cancer diagnosis, Kristen Vitale experienced shock and fear. Comprehensive, compassionate care, plus the love and support of family and friends helped her through her fight.Read Vitale's story